NCT01791192View on ClinicalTrials.gov

Study of FTY720 in Patients With Uveitis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Acute Noninfectious Posterior, Intermediate, or Pan Uveitis
Interventions
DRUG

FTY720

Fingolimod

DRUG

Oral Corticosteroid

Oral Corticosteroid

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY